Haplo transplants using ex vivo T cell depletion
Allogeneic hematopoietic stem cell transplantation (HSCT) is the best post-remission therapy for patients with acute leukemia (AL) at high risk of relapse. Advantages of having a family member as donor include: no undue delay in obtaining the graft; choice of best donor with regards to natural killer (NK) alloreactivity and cytomegalovirus (CMV) status from a panel of candidate family members; easy access to post-transplant cellular therapies like donor lymphocyte infusions and opportunity for a second graft from the original donor, or another family member in case of graft failure.
Source: Seminars in Hematology - Category: Hematology Authors: Massimo F. Martelli, Franco Aversa Source Type: research
More News: Acute Leukemia | Cytomegalovirus | Hematology | Leukemia | Stem Cell Therapy | Stem Cells | Transplants